Bausch and Mylan Settle Patent Dispute Over Trulance IBS Medication in Confidential Agreement

The legal dispute between Bausch Health Companies and Mylan Pharmaceuticals over patent rights for the gastrointestinal medication Trulance has reached its conclusion in a confidential settlement. The lawsuit, initiated to prevent Mylan from releasing generic iterations of the IBS treatment, has been officially resolved according to the recent filing in the West Virginia federal court. More details about this resolution can be examined here.